DR REDDYS LABORATORIES LTD — Regulatory Filings 2021

Dec 10, 2021

==> picture [453 x 114] intentionally omitted <==

December 10, 2021

To, The Secretary BSE Limited National Stock Exchange of India Ltd. New York Stock Exchange Inc. NSE IFSC Limited

Dear Sir/ Madam,

Sub: Intimation

This is to inform you that the Company has received approval from the U.S. Food and Drug Administration for ANDA 207577 (VeraRing). The Company is evaluating further steps in relation to this product.

This is for your information.

Yours faithfully, For Dr. Reddy's Laboratories Limited

VIVEK Digitally signed by VIVEK MITTAL MITTAL Date: 2021.12.10 21:08:41 +05'30'

Vivek Mittal

Global General Counsel and Compliance Officer